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Kevin L Neff, David P Argue, Alvin C Ma, Han B Lee, Karl J Clark and Stephen C Ekker*Abstract
Background: Recent studies of transcription activator-like (TAL) effector domains fused to nucleases (TALENs)
demonstrate enormous potential for genome editing. Effective design of TALENs requires a combination of
selecting appropriate genetic features, finding pairs of binding sites based on a consensus sequence, and, in some
cases, identifying endogenous restriction sites for downstream molecular genetic applications.
Results: We present the web-based program Mojo Hand for designing TAL and TALEN constructs for genome
editing applications (www.talendesign.org). We describe the algorithm and its implementation. The features of
Mojo Hand include (1) automatic download of genomic data from the National Center for Biotechnology
Information, (2) analysis of any DNA sequence to reveal pairs of binding sites based on a user-defined template, (3)
selection of restriction-enzyme recognition sites in the spacer between the TAL monomer binding sites including
options for the selection of restriction enzyme suppliers, and (4) output files designed for subsequent TALEN
construction using the Golden Gate assembly method.
Conclusions: Mojo Hand enables the rapid identification of TAL binding sites for use in TALEN design. The
assembly of TALEN constructs, is also simplified by using the TAL-site prediction program in conjunction with a
spreadsheet management aid of reagent concentrations and TALEN formulation. Mojo Hand enables scientists to
more rapidly deploy TALENs for genome editing applications.
Keywords: TAL effector, TALEN, Genome editingBackground
TAL domains exhibit programmable, sequence-specific
binding to DNA, a feature that makes them a valuable
addition to the tools of the molecular biologist. In
particular, TAL domains may be used in combination
with endonucleases to cause double-strand breaks which
are exploited for genome editing, either by error-prone
non-homologous end-joining repair of double-strand
breaks or insertion of new sequence by homologous
recombination. These exciting possibilities depend on
the ability of a molecular biologist to design TAL binding
sequences for specific genomic regions.
Sequence-specific DNA binding by TAL effectors is
accomplished by individual sub-domains of 33–35
amino acids. These repeat variable di-residue (RVD)
[1,2] domains contain a central pair of amino acids that
determine the base to which it binds. A variety of these* Correspondence: ekker.stephen@mayo.edu
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reproduction in any medium, provided the orRVDs are found in nature, but artificial TAL effectors
typically include: adenine=NI, cytosine=HD, guanine=NN,
and thymine=NG. For example, these RVDs are used in the
one-pot Golden Gate [3], FLASH [4], unit assembly [5], or
iterative capped assembly [6] reactions to construct
sequence-specific DNA binding proteins.
The TAL domain can bind nearly any DNA sequence.
Early work on TAL effectors indicated a consensus
sequence where a thymine must precede the binding
site, followed by [ACG] and [CGT] [1-4,6]. These
requirements are remarkably nonrestrictive, which
makes the TAL proteins useful for targeting most genes
and regulatory elements of sufficient length. Recent
work, however, indicates that only the first of these
consensus sequence rules appears to be a measurable
constraint on TALEN design [7] (ALM, unpublished
results), though even that may not be absolute when
using appropriately designed N and C termini [6-8].
In the context of genome editing, software for designing
binding sites for TALENs should be flexible and able to. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.biomedcentral.com/1471-2105/14/1target both exons and introns. Also, detecting TALEN
activity is often facilitated by restriction fragment length
polymorphism (RFLP) assays (for example, [9]). Access to
design software in a context suitable for use by molecular
biologists and life scientists is also essential for TALEN
use by the field.
Results and discussions
The Mojo Hand algorithm consists of multiple steps:
user definition of sequence source, retrieval of non-
FASTA sequence, identification of candidate TALEN sites,
selection of restriction enzyme sites for TALEN efficiency
analysis, and output to a text or .csv file. The output can
be used directly or pasted into a supplied spreadsheet to
ease in assembly of the designed TALENs. The process is
depicted in Figure 1.
Sequence input
Entering the sequence to be targeted by the TAL effector
may be accomplished through automatic download
of the gene through the NCBI Gene or Nucleotide
databases or FASTA-formatted text file. Users specify the
unique identifier for the gene of interest. Then the exons
and introns of which are retrieved using E-Utilities [10],
the API for Pub-Med and other NCBI databases.
To process subsequences (exon or intron) in genes
downloaded from NCBI Gene, Mojo Hand requires at
least one mRNA, CDS, misc RNA, or exon feature. NoGene ID
(NCBI Gene Database)
TAL Site Finding Algorithm
Report
(Text or .CSV output file)
Contig Beginning &
End Indices
(NCBI Nucleotide Database)
Enter RVDs into Spreadsheet
File (FASTA)
Customized TALEN recipe
TALEN Assembly Reaction
Restriction Site Identification
Figure 1 Flowchart of Mojo Hand. Inputs are the Entrez Gene
identifier, a nucleotide fragment, or a text file containing the
sequence in FASTA format. The output is a report containing
possible binding sites, suitable restriction sites, and RVDs. This
output can be further processed with the included spreadsheet,
which produces a customized recipe for each TALEN.subsequence information is used when users enter an
arbitrary sequence through FASTA files or Nucleotide
requests. The Gene record must also include genomic
location information so that the correct genomic
sequence may be requested from the NCBI Nucleotide
database. In a random sample of genes from diverse
organisms, we found that 80% of genes were precisely
located. Of these, we noted that 63% had at least one
mRNA record, 89% had at least one CDS record, and 4%
had at least one miscellaneous RNA record (Table 1).
Only 5% of the genes lacked all subsequence features
(below). In some cases, features for several genes (other
reading frames, especially on the opposite strand) are
annotated but Mojo Hand can determine which feature
to use based on the gene symbol and its aliases.
However, when multiple mRNA features are included
for the same gene, there is no obvious way to determine
which is most appropriate, so Mojo Hand selects the
first feature found unless the user specifies a preference
by index (or by transcript identifier). Similarly, because
CDS records lack transcript or other unique tags, the
user may only specify an index preference. Exon features
are the smallest defined feature used as a group. Therefore,
no further subsequence selection can be made.
Many genes are not fully annotated and may not have
annotated mRNA features. Mojo Hand prefers mRNA
features, but if none are found, CDS and miscellaneous
RNA records may be used. If none of these subsequence
features exist, the entire sequence is used. The mRNA
record is given the highest priority because it gives the
user flexibility in selecting any exon. However, users may
also set the priority to CDS records (−−cds-index=1)
that do not contain promoter and other regulatory
elements that may complicate results.Table 1 Frequency of various types of GenBank features
Freq exon mRNA CDS misc RNA
0 1978 763 213 1975
1 47 993 1416 71
2 15 188 305 5
3 4 71 94
4 2 20 9 1
5 3 8 6
6 1 4 3
7 1 2 4
8 1 3
Frequency of feature count for 2052 randomly selected genes. Gene
annotations often do not include mRNA records, but most (95%) have at least
one CDS record. Miscellaneous RNA features are relatively rare. Genes may
also contain multiple subsequence features that include variations in exon
locations, identical reports from multiple authors, or genes in other reading
frames. This table only includes genes for the ~80% of genes for which precise
genomic location.
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the entire sequence. Depending on the input, some
flanking sequence may be included for further analysis.
The flanking sequence is desirable because some exons
are short compared to the length of the TAL binding
site. Flanking sequence may also be needed for selecting
a restriction enzyme that cuts only once in an amplicon
of specific length, especially for binding sites that occur
near the ends of an exon or for very short exons as
illustrated in Figure 2.
NCBI access
Sequence data was downloaded using ESummary and
EFetch – URL-based methods of requesting information
from the various NCBI database. The gene of interest
(e.g. gene ID 567858) is requested by the unique identifier
in the Gene database first. Mojo Hand then constructs a
request for a detailed record based on the genomic location
as defined by the RefSeq accession number and indices of
the beginning and end of the sequence. The source of these
3 parameters can be automatically determined from the
XML output of an ESummary request from a Gene data-
base or manual entry at the command line. For example,
Gene 567858 can be requested by Gene Identifier or its
location NC 007118.5, 21501610–21527471. This identifier
and range define the gene of interest and may be used if
the unique identifier in Gene does not produce the desired
result. Mojo Hand may also be used to find binding sites in
sequences that are not designated as a gene by NCBI. Mojo
Hand then requests the detailed record from Nucleotide ina)
b)
TAL Site 1 Space
ClaI
Ampli
TAL Site 1
Prefix
Postf
Long Flanking Sequence
Exo
Short Flanking Sequence
3’
5’
Figure 2 Schematic of a TALEN and its flanking sequence. a) An exon
processing TAL sites that are near the ends of an exon or for very short ex
within the amplicon. Binding sites may be defined with a prefix or a postfi
measure the effect of TALENs, the uniqueness of the enzyme recognition s
b) Test sequence designed with only one TALEN site. The prefix thymines
enzyme is in boldface.XML format using EFetch, captures the beginning and end
points of the exons from the mRNA section, and stores the
genomic sequence for later analysis. The forward or reverse
strand is requested based on the beginning and end indices
mentioned above. Because any number of mRNA features
may be available, Mojo Hand parses the XML to find those
features that are designated with the same symbol as the
gene of interest. This procedure distinguishes between the
gene of interest and other genes encoded in another
reading frame. Some records (e.g. gene ID 32619) have
many mRNA entries for the gene of interest. Since there is
no automatic way to determine which entry is the most
appropriate, the first entry is used. In cases of manual entry
of gene location, no symbol is available and the first mRNA
is used, and a warning issued. Troublesome cases may be
handled by downloading the gene, extracting the exons
manually and using the file input mode.
The length of the requested sequence is modified to
include a user-defined number of bases upstream and
downstream of the gene. If the gene is very near the
beginning of the contig, some of the sequence may
be undefined and is filled with placeholders. Likewise,
if the requested sequence falls near the end of the
contig such that the trailing flanking sequence extends
beyond its end (e.g. gene ID 802118), placeholders are
added.
Records containing long sequences (e.g. gene ID 19091,
1.2 million base pair (bp)) are processed somewhat differ-
ently. The XML output is not processed beyond the end of
the GSeq feature table field.TAL Site 2
r
con
TAL Site 2
ix
n
3’
5’
with TALEN binding site. The short flanking sequences are needed for
ons. The long flanking sequence is used to find enzymes that cut
x. If restriction fragment length polymorphism (RFLP) is used to
ite is found on the span including both long flanking sequences.
are indicated with minuscules. The recognition site for the restriction
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We designed Mojo Hand to identify TAL binding sites
based on a user-defined template. We initially used the
template sequence of Ts[ACG][CGT].*Te. The notation
s and e indicate the start and end of the binding
sequence, bases enclosed in brackets represent a choice,
and .* indicate zero or more bases for which there is no
preference. So this template will identity TAL binding sites
that start with a T, are followed by A, C, or G (not a T),
and are followed by a C, G or T (not an A). Another
template, based on the work of Sun and coworkers [7], is
Ts.*e. In practice, we have found no substantial functional
constraints besides the initial 5’ T bp, so we now use this as
the default template sequence parameter for Mojo Hand.
In addition to the constraints described above, the user
specifies a range of allowed lengths for the binding sites
and the spacer. The algorithm generates the entire set of
possible binding sites based on these lengths. Each
candidate binding site is then filtered based on TAL-site
restrictions. The candidate sites are made by iterating
the possible lengths (Figure 2a) through the user-defined
ranges for binding site and spacer lengths. Default values
are provided: 15–17 bp for the binding sites, 15–16 bp
for the spacer.
When the length of an exon is long, execution time
may be extensive and the number of TALEN sites
becomes unusably large. Therefore, for long exons, some
binding sites are skipped by incrementing the beginning
of the first TAL site by values larger than unity. For
exons longer than 1000 bp, the increment is 10; for
exons longer than 5000, the increment is 20. Using this
skipping method and the classical consensus sequence,
we observed that many binding sites were found in our
test set (35 genes, listed below). Every possible binding
site may be obtained by submitting fragments of length
999 base pairs or less as a FASTA file or NCBI Nucleotide
request.
Restriction enzyme analysis
The biological effect of TALEN activity may be observed
in several ways, including restriction fragment length
polymorphism (RFLP), sequencing, and phenotype. If
RFLP will be used as an evaluation approach, a restriction
site should be present within the space between the TAL
binding sites. In conjunction with double-strand break
repair by error-prone non-homologous end-joining
(NHEJ), the nearby restriction site is often disrupted. We
subjected candidate binding site pairs and spacers to
further analysis to find those candidates with unique
restriction-enzyme binding sites within their spacer
region. If the user requests the single TAL binding site
option, no enzyme analysis is performed.
We used REBASE [11], a database of restriction
enzymes hosted by New England Biolabs (NEB), as thedefault restriction enzyme database collection within
Mojo Hand. We use only the subset of enzymes that are
commercially available. Future releases of the REBASE
database may be downloaded and used in the place of
the version distributed with this manuscript. Custom in-
house databases may also be used if the format matches
that of REBASE. We also used results published by NEB
[12] to determine which enzymes were compatible with
several PCR buffers (standard, Thermopol, Phusion, and
Crimson). These scores are rescaled on the range [0,9]
and displayed with each enzyme. Formal and prototype
names (first described enzyme of a particular family) are
displayed for ease of use. Mojo Hand permits selection
of enzyme site screening by vendor(s). Narrowing
the selection decreases computational load thereby
decreasing processing time for TALEN site selection
using Mojo Hand.
Mojo Hand output
The output of Mojo Hand is either a flat text file or
HTML that includes the sequences to which the TAL
proteins will eventually bind, RVDs, and enzymes that
cut in each spacer (Figure 3a) or a downloadable
comma-separated values (.csv) file that can be imported
into common programs like Microsoft Excel (Figure 3b).
The binding sites are denoted TAL1 and TAL2, as
illustrated in Figure 2b. The first site and spacer are
considered the forward direction, regardless of the
strand in the NCBI Nucleotide database. The reverse
complement of the second binding site is also provided
to show the nucleotide sequence to which the TALEN
protein will bind.
The gene symbol is indicated at the beginning of each
TALEN site. The notation symbol E# indicates which
exon each binding site was found within. The prefix E
indicates that the region of interest was an exon; I for
intron, and A when no subsequence region was available
and the entire sequence was used.
The position and length of each binding site are
provided. These values are relative to the beginning of
the subsequence fragment (exon or intron) and include
the user-defined short flanking sequence. The notation
#–#(#) indicates the first and last index of the binding
site, with the length in parentheses.
The restriction sites for RFLP are listed for each TALEN
site. The enzyme name is listed with its prototype. The
compatibility of the enzymes with full-strength PCR buffer
[12] is listed, rescaled so that it falls on the range [0,9], with
0 representing no activity. The position of the first base of
the enzyme’s recognition sequence is given for nucleases
that cut only once in the amplicon (binding site with de-
fault of 150 flanking bp on either end). The minimum dis-
tance to the second cut site is configurable (default = 80
bp). If an enzyme cuts in two positions that are at least this
Figure 3 Example output of Mojo Hand. a) Screen-shot of output from Mojo Hand for zebrafish gene flt3 Exon 1. Of all possible TALEN
binding sites, this is Site 99. The record includes the binding sequences in proper orientation, the RVDs (tab delimited in normal output for easy
transfer to a spreadsheet) and the restriction enzymes that could be used. Note that this example has only a single cutting site so the absolute
position of the beginning of the restriction site is given but the column for relative position of the second cut is empty. b) Screen-shot of
downloaded spreadsheet in .CSV format of the same example.
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to the first restriction site. The indexing is based on the
beginning of the subsequence fragment, including the long
flanking length. If using the Mojo Hand web service,
enzyme restriction site matches are highlighted in black in
the spacer while reverse complement restriction site
matches are highlighted in red.
TALEN recipe generator
Commonly used TALEN assembly protocols involve a
large number of plasmids [3]. Mojo Hand includes a
spreadsheet that aids in TALEN formulation that may be
used in conjunction with the Golden Gate method and the
TALEN DNA kit from Addgene (TALEN Kit #1000000016;
Cambridge, MA, USA)[3,9,13]. Mojo Hand outputs tab-
delimited or CSV downloadable RVD sequences, which can
be transferred into the spreadsheet using the clipboard.
The spreadsheet then produces recipes that facilitate the
molecular assembly of TALENs.
Verification of Mojo Hand and measurement of TALEN
activity
To prospectively test the Mojo Hand software, we
designed TALENs targeting zebrafish flt3 sequence using
Mojo Hand. A 450 bp genomic fragment including Exon1 was used as input. An Exon 1 targeting TALEN pair
with 15-RVD binding sites including a 5’ upstream T
nucleotide at both arms was chosen, which has a 16 bp
spacer and a unique NsiI site in the spacer (Figures 3
and 4). The TALEN constructs were subsequently
synthesized with the Golden Gate Method [3] using the
GoldyTALEN scaffold [9,13]. In vitro transcribed
mRNAs (mMessage mMachine T3 kit, Life Technology,
Carlsbad, CA, US) encoding the TALEN pair were
injected into the cytoplasm of 1-cell stage wild-type
zebrafish. At 48 hours-post-fertilization (hpf ), genomic
DNA was extracted from single and groups of 10 pheno-
typically normal embryos. The in vivo activity of the
TALEN was screened by RFLP assay as previously
described [9]. In embryos injected with the TALEN
mRNA, uncut PCR product was detected representing
the loss of NsiI site through TALEN-induced small
deletion, with the percentage of converted chromosomes
measured to be 84 ± 5% (average of three different
experiments). These results demonstrated a successful
TALEN design with Mojo Hand. We have conducted a
separate prospective analysis of 12 more TALENs made
using Mojo Hand, with each pair garnering over 20% activ-
ity and the set averaging over 50% converted chromosomes
in this zebrafish embryo assay (data not shown).
Figure 4 In vivo activity of Mojo Hand-designed TALEN. a) Detail design of TALEN binding site targeting zebrafish flt3 Exon 1 sequence.
b) Description and results of the RFLP assay showing targeted small deletion (loss of NsiI recognition sequence) introduced by the Mojo
Hand-designed TALEN pair. Primers for RFLP assay: Forward-TGAAAGTCTTCTTGCCTCTGTTC; Reverse- CAGCTGTAAATGAGTCTCACAGTT.
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Mojo Hand is available as a web service at www.talendesign.
org. The site allows access to the program without the
trouble of installation and with the ease of a familiar inter-
face. Point-of-use help is available for each field. The source
code and spreadsheet are also available for non-commercial
use with applicable license.
Conclusions
We developed Mojo Hand based on an initial training
set of 35 genes, further tested the program with users
from 3 separate laboratories, and finally conducted a
prospective study of over a dozen TALEN pairs. During
the initial vetting process, we showed that the correct
sequences were downloaded from NCBI databases using
NCBI nr/ntBLAST [14]. We manually confirmed that
the Mojo Hand predicted binding sites were within the
expected exon of the correct gene in all cases. We also
compared Mojo Hand output to manually retrieved
GenBank records and verified several binding sites to
ensure that they occurred in the correct exon and that
the prefix requirements (a 5’ thymine, in most cases)
were satisfied. Our test set was constructed so that
different numbers (0–3) of subsequence features were
present, allowing us to assess how Mojo Hand prioritizes
mRNA, CDS, and misc RNA features. We included
genes with multiple aliases and features labeled with
an alias to test if all appropriate subsequence records
were found.
Mojo Hand complements previously described software
such as the ISU TALEN Targeter [3,15] because Mojo
Hand addresses the difficulty of downloading the sequence
and extracting exons (or introns) based on annotation
from GenBank. The ISU TALEN Targeter currently onlyaccepts sequences entered in a text box or FASTA file up-
load. Mojo Hand can also screen for possible TALEN sites
using more extensive databases of restriction enzymes
(REBASE) rather than the NEB database that was recently
added to the ISU tool program. Mojo Hand also provides
a spreadsheet that bridges the gap between the RVD
output and the bench. The spreadsheet produces recipes
for individual TALENs that take into account local reagent
concentrations.
We also compared our work to idTALE, a web service
provided by King Abdullah University of Science and
Technology [16]. idTALE allows users to provide
sequence directly or by Ensembl gene identifier. Genes
are, however, restricted to just a few species (A. thaliana,
P. patens, C. elegans, D. melanogaster, S. cerevisiae), and
no restriction analysis is done. Mojo Hand appears more
flexible because any gene or sequence can be entered,
any consensus sequence may be used, and restriction
analysis is available.
Beyond the single RVD to nucleotide recognition
cipher of TALENs, other interactions that affect TALEN
activity appear to be minor. However, factors that poten-
tially affect TALEN efficiency continue to be investigated.
New information regarding TALEN design may require
rapid change of current TALEN design software. Therefore,
Mojo Hand has been designed to permit user-defined
adjustments. Beyond TALEN design based on binding
alone, Mojo Hand provides an integrated a way to down-
load the exons or introns of any gene and to filter the
results based on restriction enzyme recognition sites.
We have designed Mojo Hand to be as general as
possible, but there are several limitations. The annotated
features in GenBank can vary based on what is known
about a particular gene, so Mojo Hand may not be able
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significant proportion of randomly selected genes in
NCBI have no subsequence records (5%, Table 1), and
many (20%) have no genomic location. Also, we limit
our automatic download features to work only on genes
in the GenBank and NCBI Nucleotide databases, which
excludes much of the non-coding, non-repetitive regions
of the genome. Users may manually enter sequence data
to overcome this limitation.
Availability and requirements
The web-based interface of Mojo Hand is designed for
ease of use, and the source code is available for non-
commercial use through an applicable license to enable
programmatic interface development by advanced users.
These multiple interfaces to this flexible software tool
are designed to empower researchers to exploit TALENs
for genome editing applications.
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